Nephros, Inc.NEPHNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Recovery in Progress
Trending higher, below historical average, slight contraction.
Left:
||||
Year-over-year revenue growth rate
Latest
7.81%
↓ 16% below average
Average (39q)
9.28%
Historical baseline
Range
High:59.69%
Low:-37.64%
CAGR
-5.1%
Structural decline
| Period | Value |
|---|---|
| Q3 2025 | 7.81% |
| Q2 2025 | -9.39% |
| Q1 2025 | 26.02% |
| Q4 2024 | 10.01% |
| Q3 2024 | 8.18% |
| Q2 2024 | -7.67% |
| Q1 2024 | 8.24% |
| Q4 2023 | -13.04% |
| Q3 2023 | 5.56% |
| Q2 2023 | -4.11% |
| Q1 2023 | 44.53% |
| Q4 2022 | 6.19% |
| Q3 2022 | -15.47% |
| Q2 2022 | 32.01% |
| Q1 2022 | -21.92% |
| Q4 2021 | 7.25% |
| Q3 2021 | 13.77% |
| Q2 2021 | -17.18% |
| Q1 2021 | 17.22% |
| Q4 2020 | 10.04% |
| Q3 2020 | 34.50% |
| Q2 2020 | -37.64% |
| Q1 2020 | -19.99% |
| Q4 2019 | 2.13% |
| Q3 2019 | 34.04% |
| Q2 2019 | 30.53% |
| Q1 2019 | 9.74% |
| Q4 2018 | -6.50% |
| Q3 2018 | 26.21% |
| Q2 2018 | 38.68% |
| Q1 2018 | -24.23% |
| Q4 2017 | 41.92% |
| Q3 2017 | 6.64% |
| Q2 2017 | 17.03% |
| Q1 2017 | -1.48% |
| Q4 2016 | 56.84% |
| Q3 2016 | -6.68% |
| Q2 2016 | -13.73% |
| Q1 2016 | 15.46% |
| Q4 2015 | 59.69% |